346704-90-3

Upstream product

• 67-56-1 methanol 
• 54255-63-9 2-phenoxy-5-nitrobenzoic acid 
• 6307-82-0 2-chloro-5-nitro-benzoic acid methyl ester 
• 108-95-2 phenol 
• 112239-00-6 methyl 2-iodo-5-nitrobenzoate 
• 88-67-5 2-Iodobenzoic acid 
• 2965-22-2 methyl 2-fluoro-5-nitro-benzoate 

Downstream Products

• 346704-91-4 methyl 5-amino-2-phenoxybenzoate 
• 54255-63-9 2-phenoxy-5-nitrobenzoic acid 
• 616-71-7 2-Hydroxy-5-nitrobenzoesaeurephenylester 
• 1596360-58-5 methyl 6-[[3-(3-carbamoyl-4-phenoxy-phenyl)-2,5-dioxo-imidazolidin-1-yl]methyl]-7-methyl-pyrrolo[2,3-d]pyrimidine-2-carboxylate 
• 117821-54-2 5-Amino-2-phenoxy-benzamide 
• 1596360-09-6 5-(2,4-dioxoimidazolidin-1-yl)-2-phenoxy-benzamide 
• 1596360-99-4 ethyl 2-[(3-carbamoyl-4-phenoxy-phenyl)amino]acetate 
• 1596360-98-3 tert-butyl N-(3-carbamoyl-4-phenoxy-phenyl)carbamate 
• 1596360-97-2 methyl 5-(tert-butoxycarbonylamino)-2-phenoxy-benzoate 
• 1596360-38-1 N-[(1S)-5-amino-1-cyano-pentyl]-6-[[3-(3-carbamoyl-4-phenoxy-phenyl)-2,5-dioxo-imidazolidin-1-yl]methyl]-7-methyl-pyrrolo[2,3-d]pyrimidine-2-carboxamide 
• 1596360-81-4 9H-fluoren-9-ylmethyl N-[(5S)-5-[[6-[[3-(3-carbamoyl-4-phenoxy-phenyl)-2,5-dioxo-imidazolidin-1-yl]methyl]-7-methyl-pyrrolo[2,3-d]pyrimidine-2-carbonyl]amino]-5-cyano-pentyl]carbamate 

Relevant academic research and scientific papers

A photoredox-neutral Smiles rearrangement of 2-aryloxybenzoic acids

We report on the use of visible light photoredox catalysis for the radical Smiles rearrangement of 2-aryloxybenzoic acids to obtain aryl salicylates. The method is free of noble metals and operationally simple and the reaction can be run under mild batch or flow conditions. Being a redox neutral process, no stoichiometric oxidants or reductants are needed.

Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin

In the development of plasmin inhibitors, a novel chemotype, pyrrolopyrimidine scaffold possessing two motifs, a hydantoin-containing P4 moiety and a warhead-containing P1 moiety, is uncovered. A unique feature of the new line of the plasmin inhibitors is

BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF

Novel benzene derivatives represented by the formula (I) : wherein R1, R4 and R6 each independently represents a hydrogen atom, a halogen atom or a hydrocarbon group, R2 represents a hydrocarbon group or a heterocyclic group, R3 represents a hydrocarbon group, NR7'R7 or OR8 (wherein R7' represents a hydrogen atom or a hydrocarbon group, R7 represents a non-aromatic group, or R7' and R7 may form a ring with the adjacent nitrogen atom, and R8 represents a hydrocarbon group or a heterocyclic group), R5 represents a hydrocarbon group or a heterocyclic group (except for a quinolyl group), R5' represents a hydrogen atom, or a hydrocarbon group, or R5 and R5' may form a ring with the adjacent nitrogen atom, and R5" represents a hydrogen atom or a hydrocarbon group, which have vanilloid receptor agonist activity and are useful as a drug such as an analgesic and an agent for preventing and/or treating urinary frequency and/or urinary incontinence.